References
- Repka MA, McGinity JW, Zhang F, Koleng JJ. (2002). Encyclopedia of pharmaceutical technology. In: Boylan J, (ed). New York: Marcel Dekker.
- Liu H, Wang P, Zhang X, Shen F, Gogos CG. (2010). Effects of extrusion process parameters on the dissolution behavior of indomethacin in Eudragit E PO solid dispersions. Int J Pharm, 383:161–169.
- Zheng X, Yang R, Zhang Y, Wang Z, Tang X, Zheng L. (2007). Bioavailability in beagle dogs of nimodipine solid dispersions prepared by hot-melt extrusion. Drug Dev Ind Pharm, 33:783–789.
- He H, Yang R, Tang X. (2010). In vitro and in vivo evaluation of fenofibrate solid dispersion prepared by hot-melt extrusion. Drug Dev Ind Pharm, 36:681–687.
- Babu RJ, Brostow W, Kalogeras LM, Sathigari S. (2009). Glass Transitions in binary drug+ polymer systems. Materials Letters, 63:2666–2668.
- Mellert W, Deckardt K, Gembardt C, Hildebrand B, Schulte S. (2004). Carcinogenicity and chronic toxicity of copovidone (Kollidon VA 64) in Wistar rats and Beagle dogs. Food Chem Toxicol, 42:1573–1587.
- Zingone G, Moneghini M, Rupena P, Vojnovic D. (1992). Characterization and dissolution study of solid dispersions of theophylline and indomethacin with PVP/VA copolymers. S.T.P. Pharma Sci, 2:186–192.
- Moneghini M, Carcano A, Zingone G, Perissutti B. (1998). Studies in dissolution enhancement of acenolol. Part I Int J Pharm, 175:177–183.
- Bühler V. (2005). Vinylpyrrolidone-vinyl acetate copolymer (Copovidone). In: Bühler V, (ed). Polyvinylpyrrolidone Excipients for Pharmaceuticals. Germany: Springer-Verlag, Berlin Heidelberg.
- Wang X, Michoel A, Van den Mooter G. (2005). Solid state characteristics of ternary solid dispersions composed of PVP VA64, Myrj 52 and itraconazole. Int J Pharm, 303:54–61.
- Bühler V. (2003). Kollidon, Polyvinylpyrrolidone for the pharmaceutical industry, 7th Edn. Germany: BASF Pharma Ingredients.
- Fu J, Zhang L, Guan T, Tang X, He H. (2010). Stable nimodipine tablets with high bioavailability containing NM-SD prepared by hot-melt extrusion. Powder Technology, 204:214–221.
- Chinese Pharmacopeia. (2010). Beijing, 85–87.
- Chinese Pharmacopeia. (2010). Beijing, 922–923.
- Leuner C, Dressman J. (2000). Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm, 50:47–60.
- Bikiaris D et al. (2005). Physicochemical studies on solid dispersions of poorly water-soluble drugs: Evaluation of capabilities and limitations of thermal analysis techniques. Thermochim Acta, 439:58–67.
- Karavas E, Ktistis G, Xenakis A, Georgarakis E. (2006). Effect of hydrogen bonding interactions on the release mechanism of felodipine from nanodispersions with polyvinylpyrrolidone. Eur J Pharm Biopharm, 63:103–114.
- Vasconcelos T, Sarmento B, Costa P. (2007). Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today, 12:1068–1075.
- Zhou D, Grant DJ, Zhang GG, Law D, Schmitt EA. (2007). A calorimetric investigation of thermodynamic and molecular mobility contributions to the physical stability of two pharmaceutical glasses. J Pharm Sci, 96:71–83.
- Vasanthavada M, Tong WQ, Joshi Y, Kislalioglu MS. (2004). Phase behavior of amorphous molecular dispersions I: Determination of the degree and mechanism of solid solubility. Pharm Res, 21:1598–1606.
- Vasanthavada M, Tong WQ, Joshi Y, Kislalioglu MS. (2005). Phase behavior of amorphous molecular dispersions II: Role of hydrogen bonding in solid solubility and phase separation kinetics. Pharm Res, 22:440–448.